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Background: Exercise and diet are the cornerstones for the treatment of obesity in obese children and adolescents.
However, compensatory changes in appetite and energy expenditure elicited by exercise and dieting make it hard
to maintain a reduced weight over the longterm. The anorexic effect of hypoxia can be potentially utilized to
counteract this compensatory increase, thereby enhancing the success of weight loss. The purpose of the study is
to assess the effectiveness of four week intermittent hypoxia exposure added to a traditional exercise and diet
intervention on inducing short- and longterm weight loss in obese adolescents.
Methods/Design: In this randomized parallel group controlled clinical trial, 40 obese adolescents (20 boys and 20
girls, 11 to 15-years-old), will be recruited from a summer weight loss camp at the Shanghai University of Sport,
China. Participants will be stratified by gender and randomly assigned to either the control group or the hypoxia
group. During the four-week intervention period, both groups will exercise and eat a balanced diet. Additionally,
the control group will sleep in normal conditions, while the hypoxia group will sleep in a normobaric hypoxia
chamber (sleep high and train low). The primary outcome will be body composition and the main secondary
outcomes will be the circulating levels of appetite regulatory gastrointestinal hormones. All the outcome measures
will be assessed at baseline, after the four-week intervention, and at two months follow-up.
Discussion: Our study will be the first to evaluate the effectiveness of ‘sleep high and train low’ on short- and
longterm weight loss among obese adolescents. A potential mechanism for the appetite regulatory effect of
hypoxia will also be explored. The results of the study will provide an evidence-based recommendation for the use
of hypoxia in a weight loss intervention among obese children and adolescents. Furthermore, the clarification of
mechanisms leading to weight loss in ‘sleep high and train low’ might provide information for the development of
new strategies in combating obesity.
Trial registration: This trial was registered on 10 January 2014 at the Chinese Clinical Trial Registry with the
registration number: ChiCTR-TRC-14004106.
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Obesity is a global pandemic and its prevalence among
children and adolescents has also increased worldwide,
becoming a serious public health problem [1]. In China,
nearly 215 million people are overweight or obese, and
12% of these are children (< 17-years-old), as estimated
by the 2002 China National Nutrition and Health Survey
[2]. Obesity in childhood has been associated with an in-
creased risk of diabetes, hypertension, cardiovascular
disease and various cancers in adulthood [3,4]. Therefore,
preventing and treating obesity in children and adoles-
cents is crucial.
The causes of childhood obesity are complex and multi-
faceted involving genetic factors, environmental, and
behavioral factors. The current worldwide epidemic of
obesity is believed to be attributable to the modern living
environment which promotes a sedentary lifestyle and
excessive consumption of calorie-dense food. Accord-
ingly, a lifestyle modification including a healthy diet and
increased physical activity has been recommended as the
cornerstone of prevention and treatment of obesity. Phys-
ical activity increases energy expenditure and, in combin-
ation with a healthy diet, is effective in inducing weight
loss. However, the reduced weight achieved through
weight loss programs is hard to maintain over the long-
term. The failure to achieve longterm weight loss is be-
lieved to be caused by compensatory changes in appetite
and energy expenditure elicited by exercise and dieting.
Currently, a complete understanding of the relationship
between exercise, appetite regulation, and weight manage-
ment is lacking.
Recent research has revealed that appetite-regulating
hormones might play an important role in moderating
the interrelationship between exercise and dieting, appe-
tite, and weight regain. Among various potential appetite-
regulating hormones, the gastrointestinal hormones,
ghrelin, peptide YY (PYY), cholecystokinin (CCK) and
glucagon-like peptide-1 (GLP-1) are well studied. Ghrelin
is the only hormone that has been shown to be orexigenic,
while PYY, CCK, and GLP-1 are satiety regulatory hor-
mones [5,6]. These hormones are episodic hormonal sig-
nals occurring in unison with episodes of eating. They
signal satiation and satiety either via the vagus nerve
(which connects the gut to the brain) or via blood perfus-
ing the hypothalamus.
It is accepted that in response to weight loss, counter-
regulatory adaptations develop in the appetite regulatory
system, including the gastrointestinal hormones, defend-
ing impositions that promote a negative energy balance.
Different weight loss intervention approaches are likely to
cause different counter-regulatory adaptations in terms of
the content and the magnitude of the response. There is
some evidence suggesting that diet-induced weight loss is
associated with a compensatory increase in total ghrelin(GT) plasma levels and a blunted postprandial release of
PYY and GLP-1 [7,8]. Exercise-induced weight loss may
increase the drive to eat, as shown by increased levels of
acylated ghrelin (AG) and subjective feelings of hunger in
fasting, but it may also improve satiety as evidenced by an
increase in the late postprandial release of GLP-1 after ex-
ercise training [9].
Few studies have investigated the combined effect of
exercise and dieting on appetite in children and adoles-
cents. Based on the limited data, it appears that ghrelin
levels increase after a weight reduction program, with no
change in PYY levels [10-13]. Similarly, we have ob-
served an increase in ghrelin concentrations after weight
loss in adolescents who participated in an exercise and
diet intervention for four weeks in a summer camp pro-
gram in a previous study (unpublished data).
Recently, the effect of high altitude on appetite regula-
tion has attracted researchers’ interest. It is a widely ob-
served phenomenon that a high altitude can induce loss
of appetite [14-16]. In many studies, loss of appetite and
the resulting decrease in energy intake have been attrib-
uted to acute mountain sickness (AMS), symptoms of
which include headache and anorexia. However, loss of ap-
petite cannot merely be a by-product of AMS because an-
orexia and weight loss still persist when symptoms of AMS
have subsided [17]. Furthermore, studies conducted in nor-
mobaric hypoxia chambers, where other environmental
stressors associated with high altitude are eliminated (ex-
treme cold and physical exertion), have demonstrated that
hypoxia per se can cause reduced appetite and energy in-
take, and loss of body weight [18]. It has been suggested
that the effect of hypoxia on appetite is mediated by the
changes in gastrointestinal hormones [19-22].
It is perceivable that to promote success in longterm
weight loss, hypoxia can be implemented in a traditional
diet and exercise weight loss program, because the nega-
tive effect of hypoxia on appetite might be able to bal-
ance the positive effect of diet and exercise. Exercise and
hypoxia have been used in combination in sports to in-
duce maximal increase in aerobic endurance in athletes,
but have rarely been used in weight loss, especially in
children and adolescents. We have run several sessions
of weight loss summer camps designed for obese adoles-
cents in Shanghai, China. The effect of exercise and hyp-
oxia on weight loss has been explored in our preliminary
studies and interesting results have been generated
[23,24]. As such, we are now designing a randomly con-
trolled trial to systematically investigate the longterm
weight loss effect of exercise with hypoxia in obese ado-
lescents and determine the mediating effect of the
gastrointestinal hormones. We hypothesize that: 1) exer-
cise and hypoxia will have an additive effect on weight
loss via increasing energy expenditure and suppressing







exercise, eat a balanced diet 
and sleep in normobaric 
condition
exercise, eat a balanced diet 
and sleep in normobaric 
hypoxia chambers 
Post-intervention assessment 
2 days after the 4-week intervention
Baseline assessment 
2 days before the onset of the intervention 
Follow-up assessment 
2 month after the intervention
Figure 1 Flow of participants through the trial.
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ing effects on compensatory changes in appetite elicited
by exercise and diet in a traditional weight loss program;
and 3) changes in gastrointestinal hormones (including
ghrelin, PYY, CCK, and GLP-1), as well as in cytokine
interleukin (IL)-6, will be associated with changes in
body weight after the intervention and during follow-up.
Aims
The aims of this randomized controlled trial (RCT) are to
evaluate the effectiveness of intermittent hypoxia and ex-
ercise, in combination with a balanced diet, on inducing
short- and longterm fat loss in Chinese children and ado-
lescents, and to determine the molecular mechanisms be-
hind the benefits of hypoxia in enhancing weight loss.
Methods/Design
Design
This study is a randomized controlled clinical trial with
two parallel arms involving 40 obese adolescents. To as-
sess the effectiveness of four weeks of intermittent hyp-
oxia added to a traditional exercise and diet intervention
on inducing short (after the four-week intervention) and
longterm (at two months follow-up) weight loss in obese
adolescents, we will recruit 20 adolescent boys and 20
adolescent girls (aged 11 to 15 years) from our summer
weight loss camp. They will be stratified according to
gender and randomly assigned to two groups: the con-
trol group who will exercise, eat a balanced diet, and
sleep in a normobaric condition, and the hypoxia group,
who will exercise, eat a balanced diet, and sleep in nor-
mobaric hypoxia chambers (‘sleep high and train low’).
Outcome assessment and data analysis will be performed
by trained professionals who will be blinded to the group
assignment of subjects. The flow of participants through
the trial is shown in Figure 1.
Sample size estimation
Sample size estimation in this RCT is based on the ex-
pected fat loss following four weeks of hypoxia exposure
plus exercise and dieting. The data of our preliminary
experiment showed that the means of fat percentage de-
crease in the normoxia and hypoxia groups were 3.1 and
6.0% respectively, and the standard deviation of the
change was about 3%. It is estimated that a sample size
of 17 participants per group will be required to observe
a similar result with a power of 80%. Considering a 15%
dropout and exit rate, we will recruit 40 subjects with 20
in each group.
Ethical approval and consent
The study will be conducted according to the principles
expressed in the Declaration of Helsinki. The study proto-
col has been approved by the institutional review board atthe Shanghai University of Sport (reference number: 2014
Ethics Approval Note 1). Participants in this study are vol-
unteers. None of the measurements or the intervention
are known to entail any significant health risk. The study
has its own physician to ensure the eligibility and safety of
all participants. All data will be handled and archived con-
fidentially. The benefits and associated risks of the study
will be carefully explained and the voluntary nature of
participation will be emphasized. Informed consent and
assent will be obtained from all participants and their par-
ents or legal guardians. Participants and their parents or
legal guardianswill have the option to end the participa-
tion at any stage if they so wish. If the physician and the
principal investigator believe that there are risks of serious
adverse events in the study the trial will be stopped. The
trial is registered with Chinese Clinical Trial Registry as
ChiCTR-TRC-14004106.
Subject recruitment
Obese adolescents aged 11 to 15 years will be recruited
from the children registered for the 2014 summer weight
loss camp at the Shanghai University of Sport. A public
health nurse will assess the Tanner stage of each subject
using the Tanner grading system [25,26]. Obesity will be
defined based on body-mass index (BMI), calculated as
weight in kilograms divided by height in meters squared
(kg/m2). Although a BMI of ≥ 25 kg/m2 and ≥ 30 kg/m2
are international cutoff points for overweight and obes-
ity, for many Asian populations individuals with a BMI
of ≥ 23 kg/m2 are considered to be at increased risk and
those with a BMI of ≥ 27.5 kg/m2 at high risk [27]. Thus,
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obese adolescents. Adolescents will be excluded if they
have concomitant renal, hepatic, or cardiac disease, and/or
are being treated with drugs that could affect body weight
and appetite (such as orlistat, lorcaserin, and phentermine-
topiramate, as well as appetite suppressants).
Randomization and blinding
After a participant is confirmed to be eligible and writ-
ten informed consent has been obtained, she/he will be
randomly assigned to the hypoxia or normoxia group.
The randomization procedure, stratified according to
gender, will be conducted by an independent statistician
using a computerized randomization program. In order to
minimize the potential bias, the exercise physiologist and
the dietitian who manage the exercise training and the
diet intervention will be blinded as to whether a subject
will sleep in the hypoxia chamber or not. The hypoxia
chamber will be prepared by an independent researcher.
The researcher performing outcome assessments will be
blinded to the subjects’ intervention allocation.
Intervention
All the subjects, including both the normoxia (control)
and the hypoxia groups, will undergo four weeks of aer-
obic exercise training and dieting (eating a balanced
diet). In addition, the normoxia group will sleep in nor-
mal conditions while the hypoxia group will sleep in a
normobaric hypoxic chamber every night. All the mea-
surements will be conducted two days prior to, and
post-intervention, and repeated two months later after
the intervention (two months follow-up). Fasting blood
samples will be collected in the morning of the testing
day. In order to maximize the compliance and avoid the
occurrence of any accident the intervention will be
closely supervised by a physician, a dietitian, and an ex-
ercise physiologist.
Exercise training
The same aerobic exercise training will be applied to both
the normoxia and the hypoxia groups. Participants will ex-
ercise for six days per week, twice daily, for one hour per
session. The intensity of the exercise will be estimated
using the Metabolic Equivalent of Task (MET) score.
MET, the unit of energy expenditure, will be obtained
by dividing oxygen uptake values (ml · kg-1 · min−1) by
3.5 (1 MET is defined as resting metabolic rate that is
3.5 ml · kg − 1 · min − 1). VO2 will be measured using
Cosmed K4b2 Portable Metabolic Measurement System
(Cosmed, S.r.l., Rome, Italy) according to the manufac-
turer’s instructions.To promote participants’ interest, the
exercise training will consist of three different activities in-
cluding swimming (intensity: 6 MET), aerobic exercise
(intensity: 7.5 MET), and basketball (intensity: 6 MET).Diet modification
All participants will receive well-defined and balanced
daily meals during the four-week intervention. Dietary
recommendations will be individualized based on the in-
dividual’s basal metabolic rate and will range from 1,600
to 2,000 kcal/day. The basal metabolic rate will be calcu-
lated using the Mifflin equation [28]. The caloric intake
will be calculated based on the Chinese food chart. Each
day, three well-balanced meals will be provided with the
following calorie allocations: breakfast 35%, lunch 40%,
and dinner 25%. Each meal comprises 30% protein, 20%
fat, and 50% carbohydrate by energy. Animal and vegetable
oil and starch-rich food will be minimized, while the intake
of vegetables, fruits, bean products, rabbit meat, beef, pork,
and cellulose will be increased. This prescribed diet in-
cludes pivotal nutrients such as vitamins, minerals, essen-
tial amino acids, fiber, and polyunsaturated fatty acids.
Hypoxia exposure
To test the hypothesis that hypoxia exposure would
ameliorate the compensatory increase in appetite elicited
by exercise and diet, the experimental group (hypoxia
group) will sleep in a normobaric hypoxia environmental
chamber every night during the four- week intervention.
The advantage of using an environmental chamber com-
pared to real altitude situations is that the effects of hypoxia
can be isolated from the influence of other confounding
factors present in a real altitude situation, such as the influ-
ence of temperature, humidity, and physical activity levels.
The normobaric hypoxia will be designed to mimic an alti-
tude of 2700 m. We will use the large hypoxic training
system (Low Oxygen System, Dubai, Germany)) of the
hypoxia test laboratory of Shanghai Oriental Oasis Training
Base to simulate a hypoxic environment (14.7% O2; ap-
proximately 2700 m). After a one-day hypoxia acclimation
period, participants of the hypoxia group will sleep in the
hypoxia training laboratory for 10 hours every night (from
21:00 to approximately 7:00 the next day), seven times per
week, for four weeks.
Attrition and compliance
Due to the voluntary nature of the enrollment of the
summer weight loss camp, attrition rates will be very
low. In a pilot trial involving 50 overweight male Chinese
adolescents, 47 children completed a four-week diet
and exercise intervention, and only three children (6%)
dropped out of the study due to loss of interest. Consider-
ing the addition of a two-month follow-up, we expect a
higher attrition rate (15%) in this study. Our recruitment
plan was made based on this consideration.
Outcome assessments
Baseline assessments will be conducted two days before
the onset of the four-week intervention. Post-intervention
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two days and two months after completion of the inter-
vention, respectively. The primary outcome of the study
will be body composition and the secondary outcome
measures will include appetite score and blood levels of
gastrointestinal hormones including leptin, ghrelin, PYY,
CCK and GLP-1, as well as circulating levels of IL-6. All
the assessments will be performed in the laboratory of ex-
ercise physiology at the Shanghai University of Sport.
Primary outcome
Body composition
Body mass and height will be measured using a digital
scale (Yaohua Weighing System Co., Shanghai, China) and
a wall-mounted stadiometer (TANITA, Tokyo, Japan), re-
spectively. Body composition and fat distribution will be
measured using dual energy X-ray absorptiometry (DXA)
(GE Lunar Prodigy, Madison, Wisconsin, United States)).
The software (ENCORE, version 10.50.086, GE, Madison,
Wisconsin, United States)) will be used to analyze total
lean mass (TLM), total fat mass (TFM), total body fat per-




Peak oxygen consumption (VO2peak) for all participants
will be measured using the Cosmed (K4b2) portable meta-
bolic system. Expired respiratory gases will be collected on
a breath-by-breath basis during a submaximal treadmill
(H/P/Cosmos Pulsar 4.0, Cosmos Sports & Medical Ltd.,
Nussdorf- Traunstein, Germany) test. Exercise will start at
a speed of 2 km/h, which will be increased every 2.5 mi-
nutes by 1 km/h until 8 km/h is reached. The criterion
of exercise termination will be 80% of the maximum
heart rate (HRmax). Trained research assistants will rec-
ord heart rate and power output data at the end of each
stage. Heart rate will be measured using a polar heart rate
monitor (Polar Electro, Kempele, Finland).
Blood analyses
Fasting blood samples (2 mL, 12-hour fasting) will be ob-
tained at baseline, post-intervention, and at two months
follow-up. Serum levels of gastrointestinal hormones in-
cluding leptin, ghrelin, PYY, CCK and GLP-1, as well as
cytokine IL-6, will be measured using commercially avail-
able ELISA kits (R&D Systems, Minneapolis, Minnesota,
United States). As reported, the lower limit of sensitivity
of the assays will range between 0.8 pg/mL and 10 pg/ml.
The intra-assay coefficient of variation (CV) will be
less than 5% and the inter-assay CV will be less than
10%. Absorbance will be read at 450 nm wavelength using
a microplate reader (Bio-Rad 550, Bio-Rad, Hercules,
California, United States).Appetite assessment
Children’s appetite at baseline, during, and post-intervention,
and during follow-up will be assessed via a simple eight-
item appetite questionnaire (Additional file 1). The
questionnaire was developed by modifying the eight-item
Council on Nutrition Appetite Questionnaire (CNAQ).
The CNAQ is a short, simple, appetite assessment tool,
which has been validated and proved to be able to predict
weight loss in community-dwelling adults and nursing
home residents [29]. We modified the CNAQ to reflect
the nature of our intervention.
Data management and statistical analysis
Data generated in the study will be collected and sum-
marized using mean (standard deviation) values. Group
differences in demographical and clinical characteristics
at baseline will be tested using a two-sample t-test for
quantitative data and chi-square test for qualitative data.
Repeated measures analysis of variance (RM ANOVA)
will be used to analyze the main effect of treatment and
potential time-by-treatment interactions. For these ana-
lyses, parametric assumptions of the normality and ho-
moscedasticity will be checked using standard tests and
graphical methods. If those assumptions are violated,
data transformation and non-parametric procedures will
be considered sequentially. Multivariate regression ana-
lysis will be performed to analyze the relationship between
changes in body composition, appetite score, and gastro-
intestinal hormones following intervention and during
follow-up. Multiple models will be developed and tested
for different sets of outcome measures and regressor vari-
ables. All statistical analyses will be performed using
the Statistical Package for the Social Sciences (SPSS, Inc.,
Chicago, Illinois, United States) for Windows version 18.0,
and a significance level of 0.05 will be used.
Discussion
To the best of our knowledge, our study will be the first
to evaluate the effectiveness of ‘sleep high and train low’
on short- and longterm weight loss among obese adoles-
cents. The study will focus on obese adolescents due to
the rising prevalence of obese children in China and the
adverse impact of childhood obesity on adult health.
Adolescent obesity has been attributed mainly to a sed-
entary lifestyle and an unhealthy diet. In China, a great
effort has been made to use exercise and dietary inter-
vention to treat obesity and metabolic disorders in chil-
dren. However, the weight rebound following most of
the weight loss programs has made such an effort fruitless.
The weight rebound is believed to be caused by the com-
pensatory increase in appetite induced by exercise and
diet. Conceivably, the agent that can counteract this com-
pensatory effect will benefit obese patients in achieving
longterm weight loss. Hypoxia is potentially one of such
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served and might be utilized to dampen the appetite com-
pensatory effect of exercise and diet, thereby promoting
the success of weight loss in the longterm. Due to the pro-
found benefits of exercise training and diet in the obese
population, we do not expect to use hypoxia as a replace-
ment, but rather as a supplement to exercise and diet
intervention. Therefore, children in the control group will
undergo the same exercise training and diet as the hypoxic
group in order to evaluate the value of hypoxia in promot-
ing weight loss, and minimizing weight rebound after
intervention.
Instead of using continuous hypoxic exposure such as
high altitude, we choose to use intermittent hypoxic ex-
posure, which has been recommended as an option for
the free-living obese population [30]. The effect of inter-
mittent hypoxia exposure on weight reduction has been
reported previously. In a model of diet-induced obese
mice, it has been shown that intermittent hypoxic expos-
ure induced decreases in body mass, blood glucose levels,
and cholesterol erythropoietin concentrations [27,31]. In a
few human studies, the synergistic effect of exercise and
hypoxia in treating obesity and associated metabolic disor-
ders has been demonstrated, where low intensity exercise
training at normobaric hypoxic condition (15% O2) led to
more weight loss and greater improvement in metabolic
health compared to training at ambient conditions (21%
O2) [32-34]. However, further evidence-based studies are
needed to carefully evaluate the therapeutic value of hyp-
oxia and the model of utilization in treating obesity, espe-
cially in children. Intermittent hypoxia exposure, as used
in the ‘sleep high and train low’ paradigm has been pro-
posed for endurance athletes to maximally enhance their
endurance exercise capabilities, however the clinical use
of intermittent hypoxia in the management of cardiometa-
bolic diseases has rarely been tested. Our study will be the
first to evaluate the effect of ‘sleep high and train low’ on
weight loss in obese adolescents. Through monitoring a
wide spectrum of health indices including blood pressure,
heart rate, vital capacity, blood glucose and insulin levels,
blood lipid profile, and immune function we will careful
monitor any possible side effects associated with hypoxia
exposure.
Furthermore, we will investigate the mechanism for
the effect of hypoxia on weight management. We will
focus on the regulatory effect of ‘sleep high and train
low’ on gastrointestinal hormones levels. In addition, we
hypothesize that the cytokine IL-6 might also play a role
in mediating the appetite regulatory effect of exercise
(positive effect) and hypoxia (negative effect). The clarifi-
cation of mechanisms leading to weight loss in ‘sleep
high and train low’ might provide information for the
development of new strategies in combating obesity in
the future.Trial status
A pilot study involving a small group of overweight chil-
dren has been completed based on the summer weight
loss camp at our institution in 2013. The intervention
modality has proven to be tolerated very well among
children and has been effective in inducing significant
weight loss. For the official trial, participant recruitment
will start in April 2014. Baseline measurements will be
taken in June 2014, and the four-week intervention will
be completed by August 2014, which will be followed by
a two month follow-up. Feedback on the preliminary re-
sults of participants’ health status will be provided to the
participants upon completion of the study.
Additional file
Additional file 1: Appetite questionnaire.
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